首页|基于SNP-array的全基因组单体型分析在病理性小拷贝数变异的植入前遗传学检测中的拓展应用

基于SNP-array的全基因组单体型分析在病理性小拷贝数变异的植入前遗传学检测中的拓展应用

扫码查看
目的 探讨基于单核苷酸微阵列技术(SNP-array)的全基因组单体型分析在病理性小拷贝数变异(CNV)的植入前遗传学检测(PGT)中的可行性和有效性。方法 选择2020年5月至2023年11月在中山大学附属第一医院生殖中心因一方携带有致病性小CNVs而要求行PGT的夫妇为研究对象。对常规ICSI受精后的囊胚进行活检,活检后的样本经全基因组扩增后进行SNP-array的检测。构建家系单体型,在CNV所在区域,将胚胎单体型与家系中携带致病性小CNVs的先证者单体型进行比对,确定胚胎是否带有风险单体型,从而确定胚胎是否携带有致病性小CNV。结果 共完成14个PGT周期,活检胚胎数71个,其中39个胚胎未遗传上一代的致病性小CNVs,29个胚胎带有致病性CNVs,3个胚胎为X染色体CNVs的携带者。目前完成移植周期9个,其中6个移植周期成功获得临床妊娠,已有5例行羊膜腔穿刺术,结果均未发现遗传了上一代的致病性CNVs。活产婴儿3个,出生后随访迄今为止均显示身体健康。所有家系的产前诊断结果与胚胎检测结果一致。结论 基于SNP-array的全基因组单体型分析对低于植入前非整倍体筛查(PGT-A)检测范围的小片段CNV具有一定的有效性和可行性。另外,通过对定制的大量SNP位点进行定量分析,还可以同时完成胚胎的非整倍体筛查。
Expanded application of whole-genome haplotype analysis based on SNP-array in preimplantation genetic testing for pathogenic small copy number variations
Objective:To explore the feasibility and effectiveness of whole-genome haplotype analysis based on single nucleotide microarray technology(SNP-array)in preimplantation genetic testing(PGT)for less than 5 Mb of pathological copy number variations(CNV).Methods:Couples who sought for PGT due to pathogenic small CNVs at the Reproductive Center of the First Affiliated Hospital of Sun Yat-sen University from May 2020 to November 2023 were recruited.The blastocysts fertilized through conventional ICSI were biopsied,and the biopsied samples were subjected to whole-genome amplification and SNP-array detection.The family haplotype was constructed,and the embryo haplotype was compared with the haplotype of the reference carrying the small pathogenic CNV in the family to determine whether the embryo carried the risk haplotype in the area the CNVs located for evaluating whether the embryo carried the small pathogenic CNVs.Results:A total of 14 PGT cycles were completed,and 71 embryos were biopsied.A total of 39 embryos were determined as unaffected,29 as affected,and three as X-linked carriers.In 9 embryos transferred,clinical pregnancies successfully achieved in six transfer cycles,and 5 had undergone amniocentesis.The results showed that no pathogenic CNVs inherited from the previous generation were found.Three babies were born alive and all have been shown to be in good health during postnatal follow-up so far.The results of prenatal diagnosis in all families were consistent with the results of embryo testing.Conclusions:Whole-genome haplotype analysis based on SNP-array is efficient and feasible for the detection of small pathogenic CNV lower than the range of preimplantation aneuploidy screening(PGT-A).In addition,embryo aneuploidy screening can also be completed by quantitative analysis of SNPs at the same time.

Copy number variantsPreimplantation genetic testingSingle nucleotide polymorphism arrayHaplotype analysis

王静、马远林、郭婧、李荣、潘家富

展开 >

中山大学附属第一医院,广东省生殖医学重点实验室,广州 510080

拷贝数变异 植入前遗传学检测 单核苷酸微阵列技术 单体型分析

2024

生殖医学杂志
北京协和医院 国家人口计生委科学技术研究所

生殖医学杂志

CSTPCD
影响因子:1.24
ISSN:1004-3845
年,卷(期):2024.33(12)